These data demonstrate that higher GSDM gene expression (except for PJVK) may be associated with an increase in immune cell infiltration into the tumor, together with a decrease in tumor purity and stemness activity, thus potentially improving patient outcomes. This evidence concerns the gene GSDMA and neoplasm.